Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZNF733P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
YME1L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
VEGFA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GLI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC730098 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
ZNF430 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC33 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRIK1-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPBD1P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOB3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MFSD2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFR2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PAGE5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL23AP53 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TPTEP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on